To determine the activation of RhoA and Rac1 in FLSs of RA, OA, and patients of knee trauma, and the effect of Smo on RhoA and Rac1 activation in RA-FLSs, pull-down assays were performed according to the manufacturer’s protocol (RhoA activation assay kit and Rac1 activation assay kit, Millipore, MA, USA). Briefly, at 80% confluency, FLSs were lysed and the lysates were collected and stored at −80°C for the pull-down assay. Thirty microliters of the Rho or Rac1 Assay Reagent were added to 500 μl cell extract and the reaction mixtures were incubated for 45 min at 4°C with gentle agitation. After brief centrifugation (10 s, 14,000 × g, 4°C), the agarose beads were washed three times with 1× MLB, the supernatant was removed, and the agarose beads were re-suspended in 2× Laemmili-reducing sample buffer. Bound proteins were collected and examined by Western Blot analysis as previously described. GTP-RhoA or GTP-Rac1 was detected using anti-RhoA (3 μg/ml, Millipore, MA, USA) or anti-Rac1 antibodies (1 μg/ml, Millipore, MA, USA), respectively.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.